Why the study?
Does oral NG-monomethyl-L-arginine reduce glomerulonephritis and arthritis in MRL-lpr/lpr mice?
Population
MRL-lpr/lpr mice
Comparison
Oral administration of NG-monomethyl-L-arginine vs Normal strains and MRL- and B6-lpr/lpr congenic…
Design
Preclinical
Authors
Loading...
Should not change clinical practice; hypothesis-generating for nitric oxide synthase inhibition in autoimmune disease.
Does oral NG-monomethyl-L-arginine reduce glomerulonephritis and arthritis in MRL-lpr/lpr mice?
Inhibition of nitric oxide synthase with NG-monomethyl-L-arginine prevents glomerulonephritis and reduces inflammatory arthritis in a murine model of autoimmune disease, suggesting NO plays a key role in autoimmune pathogenesis.
Weinberg et al. (1994) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: